Pfizer, Ema: “ok as a booster for 5-11 year olds”

EMA green light for Pfizer bivalent for Omicron 4 and

(Finance) – They are 17,364 the new cases of coronavirus registered in our country in the latest 24 hours compared to just over 138 thousand swabs processedbetween molecular and antigenic with the 12.6% positivity rate.

The number of patients admitted to intensive care is decreasing 142 in total, one less than yesterday, and the hospitalized with symptoms, 3,600 in total and 32 less than yesterday. I am instead 44 the victims. These are the data released today by Ministry of Health.

“This week the incidence is decreasing, RT shows a tendency to stabilize, and remains below the epidemic threshold. The employment rate in the ordinary wards is al 5.7%, in resuscitations at 1.4%, well below any criticality threshold. Given the availability of new vaccines adapted to circulating variants, it is especially important for the frail and over 60 years old to carry out booster doses to reduce the risk of serious illness and hospitalization “. Gianni Rezza, in a video commenting on the weekly data.

Interesting data also comes from Altems Report: in the past week there has been a decline in infections, with a national value equal to 152 new cases per 100,000 residents. In the last 30 days, the highest incidence data were recorded in the Center (148 new cases per 100,000 residents) and the North-West (149 new cases per 100,000 residents). There lethality, on the other hand, or the ratio between the number of deceased patients and Covid-19 positive subjects in a certain time interval, seems to remain constant.

Meanwhile, the green light for Pfizer-BioNTech’s anti-Covid vaccine has also arrived as a booster for children under 12. The Committee for Medicinal Products for Human Use, Chmp, of the European Medicines Agency Ema has in fact “recommended authorizing the ‘use of Comirnaty- as a booster dose for children aged 5 to 11 years “. This was announced by the EU regulatory body.

(Photo: EPA / Biontech)

tlb-finance